Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.33 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8747201 | 0.98 | GABRR1 (0.38) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| Ammonia Solution, Strong SCHEMBL9133439 | 0.98 | GABRR1 (0.38) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| Ammonia Solution, Strong SCHEMBL9153449 | 0.98 | GABRR1 (0.38) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| SCHEMBL5690748 | 0.96 | GABRR1 (0.36) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| Ammonia Solution, Strong SCHEMBL8078632 | 0.96 | GABRR1 (0.36) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| SCHEMBL8747255 | 0.87 | GABRR1 (0.31) | GABRR1LMNATDP1 | |
| SCHEMBL9810936 | 0.85 | GABRR1 (0.32) | GABRR1LMNA | |
| SCHEMBL6551964 | 0.84 | GABRR1 (0.35) | GABRR1LMNACACNA2D1CACNB3CACNA1C | |
| SCHEMBL4581476 | 0.83 | GSR (0.37) | GABRR1LMNAGABBR2GABBR1ALDH1A1 | |
| SCHEMBL284822 | 0.78 | TDP1 (0.34) | GABRR1LMNATDP1SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0815188-B1 | ALKALINE DETERGENT HAVING HIGH CONTENTS OF NONIONIC SURFACTANT AND COMPLEXING AGENT, AND USE OF AN AMPHOTERIC COMPOUND AS SOLUBILISER | AKZO NOBEL NV (NL) | 2001-09-05 | — | — | EP | claimed |
| EP-0205121-B1 | PROCESSING METHOD FOR SILVER HALIDE COLOR PHOTOSENSITIVE MATERIALS | FUJI PHOTO FILM CO., LTD. (JP) | 1991-06-26 | — | — | EP | claimed |
| US-4818646-A | DOPING WITH TRANSITION METAL COMPLEX | RICOH COMPANY, LTD. (JP) | 1989-04-04 | — | — | US | claimed |
| US-20260115334-A1 | CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY | PURDUE RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115333-A1 | CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY | PURDUE RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260045489-A1 | NEGATIVE ELECTRODES FOR ELECTROCHEMICAL CELLS | FORM ENERGY INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12362352-B2 | Negative electrodes for electrochemical cells | FORM ENERGY, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250226401-A1 | IRON POWDER, IRON ELECTRODE, IRON BATTERY, AND METHOD OF MANUFACTURE THEREOF | FORM ENERGY, INC. (US) | 2025-07-10 | — | — | US | disclosed |
| US-20250201885-A1 | ELECTROCHEMICAL STORAGE DEVICES COMPRISING CHELATED METALS | OTORO ENERGY, INC. | 2025-06-19 | — | — | US | disclosed |
| US-20250161842-A1 | PURIFICATION OF ALKALINE ELECTROLYTES | FORM ENERGY, INC. | 2025-05-22 | — | — | US | disclosed |
| US-20250146156-A1 | GENERATING AND CONTROLLING MAGNETIC FIELDS FOR ELECTROLYZER STACKS | FORM ENERGY, INC. (US) | 2025-05-08 | — | — | US | disclosed |
| US-5695915-A | BLEACHING USING A FERRIC COMPLEX SALT | KONICA CORPORATION (JP) | 1997-12-09 | — | — | US | disclosed |
| EP-0450554-B1 | Process for processing a silver color photographic material | FUJI PHOTO FILM CO LTD (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5384233-A | Storage stabilty | KONICA CORPORATION (JP) | 1995-01-24 | — | — | US | disclosed |
| US-5378588-A | Method for processing silver halide photographic light-sensitive materials which conserves and reuses overflow processing solutions | KONICA CORPORATION (JP) | 1995-01-03 | — | — | US | disclosed |
| EP-0581197-A2 | A method for processing silver halide photographic light-sensitive materials | KONICA CORPORATION (JP) | 1994-02-02 | — | — | EP | disclosed |
| US-5250397-A | Containing yellow colored cyan coupler; improved bleaching | FUJI PHOTO FILM CO., LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0534608-A1 | Stabilizing solution for lightsensitive silver halide color photographic material, and processing method making use of the stabilizing solution | KONICA CORPORATION (JP) | 1993-03-31 | — | — | EP | disclosed |
| EP-0488313-A1 | A silver halide color photographic light-sensitive material | KONICA CORPORATION (JP) | 1992-06-03 | — | — | EP | disclosed |
| EP-0450554-A1 | Process for processing a silver color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115334-A1 | CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY | FGF23, FOLH1, HDGF | GABRR1 1945/4885LMNA 1667/4885CACNA2D1 980/4885 |
| US-20260045489-A1 | NEGATIVE ELECTRODES FOR ELECTROCHEMICAL CELLS | MCU, SLC8B1, SLC9A2 | GABRR1 4750/4885LMNA 3304/4885CACNA2D1 25/4885 |
| US-20260115333-A1 | CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY | FGF23, SLC34A2, SLC34A3 | GABRR1 3715/4885LMNA 3075/4885CACNA2D1 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.